Hydrocephalus market seen reaching $4.79 billion by 2030

The hydrocephalus market is projected to grow from $3.66 billion in 2025 to $3.87 billion in 2026, with the long-range forecast pointing to $4.79 billion by 2030. The report points to wider healthcare infrastructure, stronger imaging access, and growing demand for earlier diagnosis and minimally invasive treatment as major drivers.

Why it matters: - Hydrocephalus is a neurological disorder that can cause cognitive impairment and other neurological symptoms, so earlier diagnosis and treatment can affect patient outcomes. - The market outlook signals continued demand for imaging, neurology care, and pediatric neurosurgery services tied to this condition.

What happened: - The Business Research Company released a hydrocephalus market report covering market size, trends, and global forecasts for 2026 to 2035. - The report estimates the market will rise from $3.66 billion in 2025 to $3.87 billion in 2026. - The report projects the market will reach $4.79 billion by 2030. - North America was the largest regional market for hydrocephalus in 2025.

The details: - The 2025-to-2026 increase reflects a 5.8% compound annual growth rate. - The 2026-to-2030 forecast reflects a 5.5% compound annual growth rate. - Historical growth is linked to broader access to neuroimaging, greater awareness of neurological conditions, expansion of hospital neurology departments, growth in pediatric neurosurgery, and more diagnostic imaging infrastructure. - Future growth is expected to come from more investment in neurological research, stronger demand for early diagnostic tools, wider use of advanced imaging, more minimally invasive treatment options, and higher healthcare funding for neurological care. - Hydrocephalus involves a buildup of cerebrospinal fluid in the brain’s cavities, where fluid normally flows through spaces in the brain and spinal cord. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Between the lines: - The report ties market growth to system-level healthcare expansion, not just to one device or treatment category. - Wider hospital capacity and diagnostic access can speed diagnosis and referral, which tends to support sustained demand across the care pathway. - The emphasis on minimally invasive treatment suggests ongoing pressure for procedures that reduce recovery time and complexity.

What's next: - The report expects continued growth through 2030 as governments and providers invest more in neurological care and imaging capability. - The company also added 2026 report features including market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables. - A free sample of the report is available here, and the full report is available here.

The bottom line: - Hydrocephalus remains a niche but growing healthcare market, with demand shaped by diagnosis access, neurology infrastructure, and treatment innovation.